Huntington disease (HD) is a dominantly inherited neurodegenerative disease characterized by involuntary abnormal movements, cognitive and psychiatric symptoms. Evidence suggests that energy deficit plays a critical role in the disease pathophysiology. There is however a lack of robust biomarkers for testing therapeutic strategies targeting brain energy metabolism. This study aims to measure dynamic parameters of brain energy metabolism and identify novel functional biomarkers of for use in therapeutic trials in HD. This study showed altered creatine kinase rate in patients with HD as well as altered diffusion rates of several metabolites in the corpus callosum of patients with HD.
How to access this content:
For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.
After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.
After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.
Keywords